Company: CORT
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001628280-25-022173
Chunk: 85

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 8
Chunk 85
---
 OF PROCEEDS

There were no unregistered sales of equity securities during the period covered by this report.

38

Issuer Purchases of Equity Securities

The following table contains information relating to the repurchases of our common stock in the three months ended March 31, 2025 as part of our publicly announced stock repurchase program (in thousands, except average price per share):

Fiscal PeriodTotal Number of Shares RepurchasedAverage Price Paid Per ShareDollar Amount of Shares That May Yet be Purchased Under the Program(1)January 1, 2025 to January 31, 2025— $— $184,329 February 1, 2025 to February 28, 2025— — 184,329 March 1, 2025 to March 31, 2025500 54.84 156,896 Total500 $54.84 $156,896 

(1)On January 8, 2024, our Board of Directors authorized the repurchase of up to $200 million of our common stock pursuant to our Stock Repurchase Program. The program may be modified, suspended or discontinued at any time without notice.

The following table contains information relating to the purchase of shares of our common stock in the three months ended March 31, 2025 as part of the cashless net exercises of stock options and vesting of restricted stock (in thousands, except average price per share):

Fiscal PeriodTotal Number of Shares Purchased(1)Average Price Per ShareTotal Purchase Price of Shares(2)January 1, 2025 to January 31, 2025134 $57.64 $7,710 February 1, 2025 to February 28, 2025129 67.79 8,707 March 1, 2025 to March 31, 202579 58.80 4,669 Total342 $61.72 $21,086 

(1)In January 2025, we issued 235,978 shares of common stock as part of net-share settlement of cashless option exercises, of which 124,840 shares were surrendered to us in satisfaction of related exercise cost and tax obligations. In February 2025, we issued 190,708 shares of common stock as part of net-share settlement of cashless option exercises, of which 107,705 shares were surrendered to us. In March 202